Frank Jessen
scientistMale0.0Global Dominance: 0.00%
Frank Jessen is the Director of the Department of Psychiatry and Psychotherapy at the University Hospital of Cologne. He is a prominent figure in Alzheimer's research, advocating for earlier intervention with anti-amyloid antibodies like Lecanemab to potentially enhance treatment outcomes and delay cognitive decline in patients.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Frank Jessen is the director of the Clinic and Polyclinic for Psychiatry and Psychotherapy at the University Hospital of Cologne.
Neues Medikament gegen Alzheimer: Erste Erfahrungen mit LecanemabNeue Zürcher Zeitung·
Switzerland· 2025-10-24
Switzerland· 2025-10-24
Frank Jessen is the director of the Clinic and Polyclinic for Psychiatry and Psychotherapy at the University Hospital of Cologne.
Warum das Alzheimer-Medikament erst der Anfang sein könnteNeue Zürcher Zeitung·Switzerland· 2025-09-09
Switzerland· 2025-09-09
